Zura Bio Limited Class A Ordinary Shares (ZURA) — Cash Flow-to-Debt Ratio
Zura Bio Limited Class A Ordinary Shares (ZURA) has a Cash Flow-to-Debt Ratio of -0.61x as of September 2025, meaning its operating cash flow of $-15.44 Million could theoretically repay -1% of its total liabilities ($25.49 Million) in one year. See ZURA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zura Bio Limited Class A Ordinary Shares Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Zura Bio Limited Class A Ordinary Shares across 4 annual periods. For the full cash flow conversion analysis, see Zura Bio Limited Class A Ordinary Shares (ZURA) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Zura Bio Limited Class A Ordinary Shares (2021–2024)
Year-by-year debt coverage analysis for Zura Bio Limited Class A Ordinary Shares. Check earnings quality score of Zura Bio Limited Class A Ordinary Shares to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.44x | $-28.08 Million | $19.51 Million | ▼ -103.5% |
| 2023 | -0.71x | $-15.05 Million | $21.29 Million | ▼ -1506.9% |
| 2022 | -0.04x | $-1.20 Million | $27.32 Million | ▲ +58.5% |
| 2021 | -0.11x | $-1.10 Million | $10.35 Million | — |